Back to Search Start Over

Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects.

Authors :
de Boer, Lonneke
Cambi, Alessandra
Verhagen, Lilly M.
de Haas, Paola
van Karnebeek, Clara D.M.
Blau, Nenad
Ferreira, Carlos R.
Source :
Molecular Genetics & Metabolism. May2023, Vol. 139 Issue 1, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

Immunological problems are increasingly acknowledged manifestations in many inherited metabolic diseases (IMDs), ranging from exaggerated inflammation, autoimmunity and abnormal cell counts to recurrent microbial infections. A subgroup of IMDs, the congenital disorders of glycosylation (CDG), includes CDG types that are even classified as primary immunodeficiencies. Here, we reviewed the list of metabolic disorders reported to be associated with various immunological defects and identified 171 IMDs accompanied by immunological manifestations. Most IMDs are accompanied by immune dysfunctions of which immunodeficiency and infections, innate immune defects, and autoimmunity are the most common abnormalities reported in 144/171 (84%), 44/171 (26%) and 33/171 (19%) of IMDs with immune system involvement, respectively, followed by autoinflammation 17/171 (10%). This article belongs to a series aiming at creating and maintaining a comprehensive list of clinical and metabolic differential diagnoses according to organ system involvement. • We found 171 IMDs associated with immunological involvement and provide a list of tests to aid in their diagnosis. • This represents the twelfth in a series of summaries providing a comprehensive list of metabolic differential diagnoses. • This list will be curated and updated on a continual basis in the IEMbase website. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10967192
Volume :
139
Issue :
1
Database :
Academic Search Index
Journal :
Molecular Genetics & Metabolism
Publication Type :
Academic Journal
Accession number :
163482846
Full Text :
https://doi.org/10.1016/j.ymgme.2023.107582